Gilead Sciences (United Kingdom)

Gilead Sciences (United Kingdom)

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Gilead Sciences (United Kingdom), United Kingdom, covering academic research published from 2001 to 2024. Read More.


Open Access Percentage

76%


Total
Publications

254


Total Open
Publications

192


Total
Citations

5.4K


Open Access
Percentage

76%


Total
Publications

254


Total Open
Publications

192


Total
Citations

5.4K

Wikipedia

Website

download

Breakdown

36% 32% 8% 24%

Publisher Open

36%

Both

32%

Other Platform Open

8%

Closed

24%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540Total Publications
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

35%OA Journal

OA Journal 35%

61

Hybrid 39%

67

No Guarantees 26%

44

Other Platform Open

Domain 85%

86

Institution 30%

30

Preprint 9%

9

Other Internet 8%

8

Public 3%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
86
Europe PMC
Domain
31
University of Bristol - Bristol Research
Institution
7
University of Dundee - Discovery Research Portal
Institution
4
Research Square
Preprint
4
London School of Hygiene and Tropical Medicine - LSHTM Research Online
Institution
4
University of Oxford - Oxford University Research Archive (ORA)
Institution
3
University of Nottingham - Repository@Nottingham
Institution
3
University of Milano-Bicocca - BOA - Bicocca Open Archive
Institution
3
The University of Glasgow - Enlighten: Publications
Institution
3
1 / 6

Data updated 7 April 2025

Share

Share

Share